Page 92 - New epidemiological and PSMA-expression based paradigms in salivary gland tumors

90
Chapter 5
References
1 de Ridder M, Balm AJM, Smeele LE, et al. An epidemiological evaluation of salivary gland cancer in the Netherlands (1989-2010). Cancer Epidemiol 2015; 39: 14-20
2 Valstar M, de Ridder M, van den Broek E, et al. Salivary gland pleomorphic adenoma in the Netherlands: A nationwide observational study of primary tumor incidence, malignant transformation, recurrence, and risk factors for recurrence. Oral Oncol 2017; 66: 93-99
3 Andreasen S, Therkildsen MH, Bjørndal K, et al. Pleomorphic adenoma of the parotid gland 1985- 2010: A Danish nationwide study of incidence, recurrence rate, and malignant transformation. Head Neck 2016; 38: E1364-9
4 Gnepp D. Malignant mixed tumors of the salivary glands: a review. Pathol Annu 1993; 28: 279-328
5 Przewoźny T, Stankiewicz C. Neoplasms of the parotid gland in northern Poland, 1991-2000: an
epidemiologic study. Eur Arch Otorhinolaryngol 2004; 261: 369-375
6 Bradley PJ, McGurk M. Incidence of salivary gland neoplasms in a defined UK population. Br J Oral
Maxillofac Surg 2013; 51: 399-403
7 Pia-Foschini M. Salivary gland-like tumours of the breast: surgical and molecular pathology. J Clin
Pathol 2003; 56: 497-506
8 Murase R, Sumida T, Ishikawa A, et al. Novel Therapeutic Strategies for Malignant Salivary Gland
Tumors: Lessons Learned from Breast Cancer. Int J Otolaryngol 2011; 2011: 1-9
9 Camelo-Piragua SI, Habib C, Kanumuri P, et al. Mucoepidermoid carcinoma of the breast shares cytogenetic abnormality with mucoepidermoid carcinoma of the salivary gland: a case report with molecular analysis and review of the literature. Hum Pathol 2009; 40: 887-892
10 Marchiò C, Weigelt B, Reis-Filho JS. Adenoid cystic carcinomas of the breast and salivary glands (or ‘The strange case of Dr Jekyll and Mr Hyde’ of exocrine gland carcinomas). J Clin Pathol 2010; 63: 220- 228
11 Skálová A, Vanecek T, Sima R, Laco J, Weinreb I, Perez-Ordonez B, Starek I, Geierova M, Simpson RH, Passador-Santos F, Ryska A, Leivo I, Kinkor Z MM. Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity. Am J Surg Pathol 2010; 34: 599-608
12 Boukheris H, Curtis R, Land C, et al. Incidence of carcinoma of the major salivary glands according to the WHO classification, 1992 to 2006: a population-based study in the United States. Cancer Epidemiol Biomarkers Prev 2009; 18: 2899-2906
13 Bjørndal K, Krogdahl A, Therkildsen MH, et al. Salivary gland carcinoma in Denmark 1990-2005: a national study of incidence, site and histology. Results of the Danish Head and Neck Cancer Group (DAHANCA). Oral Oncol 2011; 47: 677-682
14 Wong MHW, Dobbins TA, Tseung J, et al. Oestrogen receptor beta expression in pleomorphic adenomas of the parotid gland. J Clin Pathol 2009
15 Speirs V. Oestrogen receptor b in breast cancer: good, bad or still too early to tell? J Pathol 2002; 197: 143-147
16 Marques YMFS, Giudice FS, Freitas VM, et al. Oestrogen receptor β in adenoid cystic carcinoma of salivary glands. Histopathology 2012; 60: 609-616
17 Dost P, Kaiser S. Ultrasonographic biometry in salivary glands. Ultrasound Med Biol 1997; 23: 1299- 1303
18 Micheli A, Mariotto A, Giorgi Rossi A, et al. The prognostic role of gender in survival of adult cancer patients. Eur J Cancer 1998; 34: 2271-2278
19 Gove WR, Hughes M. Possible causes of the apparent sex differences in physical health: an empirical investigation. Am Sociol Rev 1979; 44: 126-146
20 Cleary PD, Mechanic D, Greenley JR. Sex differences in medical care utilization: an empirical investigation. J Health Soc Behav 1982; 23: 106-119
21 Berg J, Hutter R, Foote Jr F. The unique association between salivary gland cancer and breast cancer. JAMA 1968; 204: 771-774